About
About Circio
CEO Statement
Pipeline
Management Team
Board of Directors
Careers
The Norwegian Transparency Act
circRNA
Circio AB
circVec platform
Clinical programs
ONCOS-102
KRAS program
Publications
Partnering
Investors
Press releases
Events
Reports
Presentations
Prospectus
Debt
Share information
Share facts
Largest shareholders
Dividend policy
Analyst coverage
Registrar and auditor
Corporate Governance Policy
Code of Conduct
Corporate Social Responsibility Principles
Remuneration Principles
About General Meeting
General Meetings
Board of Directors
Nomination Committee
Committees
Management
Articles of Association
Contact
Media
Press releases
Events
Subscribe
Contact
Contacts
About
About Circio
CEO Statement
Our pipeline
Management Team
Board of Directors
Careers
The Norwegian Transparency Act
circRNA
Circio AB
circVec platform
Clinical programs
ONCOS-102
KRAS program
Publications
Partnering
Partnering
Investors
Press releases
Events
Reports
Presentations
Prospectus
Debt
Share information
Share facts
Largest shareholders
Dividend policy
Analyst coverage
Registrar and auditor
Corporate Governance Policy
Code of Conduct
Corporate Social Responsibility Principles
Remuneration Principles
About General Meeting
General Meetings
Board of Directors
Nomination Committee
Committees
Management
Articles of Association
Contact
Subscribe
Contact
Media
Press releases
Events
Subscribe
Contact
Contacts
Offices
Investors & Media
Search for:
All press releases
Press releases - Regulatory
Press releases - Non-regulatory
2011
2023
All years
All subjects
Corporate news
Other
All languages
English
Norwegian
November 28, 2011
Press release - Non-regulatory
9 million NOK for development of cancer vaccine
June 13, 2011
Press release - Non-regulatory
Targovax AS received a grant from Innovation Norway
